The FDA's recommendation follows a study finding that sodium polystyrene sulfonate also binds to many common oral medications, which decreases ...
In a letter to clinicians, the FDA noted five reports of unanticipated deaths that occurred from 2016 to the present in patients treated with liquid-filled intragastric ...
Approved use of the drug has been expanded to include treatment of patients with hepatocellular carcinoma who have been treated with sorafenib.
The drug is the first FDA-approved biosimilar to treat breast or stomach cancer and the second FDA-approved biosimilar to treat cancer.
The FDA suggests that clinicians should consider alternatives to eluxadoline in this population.
Clinicians should determine baseline liver function before starting patients on obeticholic acid, the FDA said.
One lot of pantoprazole sodium for injection (40 mg per vial) was recalled in December.
The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.
The recall of ED-530XT duodenoscopes by Fujifilm includes replacement of the ED-530XT forceps elevator mechanism (including the O-ring seal), ...
The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.